Dear Colleagues:

The featured article in this issue of ACCP International Clinical Pharmacist, “World Health Assembly Adopts Global Patient Safety Action Plan 2021–2030,” highlights the WHO action plan, strategic objectives, and core indicators for monitoring progress toward realizing the action plan over the next 10 years. At the practitioner level, the action plan should be viewed with the central role pharmacists assume in medication optimization.

The article titled “2021 ACCP Annual Meeting to Be Delivered On-Demand and by Virtual Meetings” announces the cancellation of the in-person 2021 ACCP Annual Meeting. Alternative plans to deliver meeting content on-demand and by virtual meetings are being developed. Given the risks associated with travel and large-group in-person gatherings, this is an opportunity for expanded reach, and I hope that many international colleagues take advantage of the revised delivery formats to access the high-quality programming that ACCP Annual Meeting attendees are accustomed to.

The title featured in this issue’s Book Highlights department is Infections in Immunocompromised Patients, the most recent release in ACCP’s Infectious Diseases Self-Assessment Program (IDSAP). Although developed for Board Certified Infectious Diseases Pharmacists (BCIDPs), the learning activities are relevant to all clinical pharmacists providing care to immunocompromised patients.

Finally, the article titled “COVID-19 Treatment Updates” presents key revisions released by the NIH COVID-19 Treatment Guidelines Panel.

Sincerely,

Wafa Y. Dahdal, Pharm.D.